Onconova Presents Positive Clinical Results for Rigosertib at ASH Meeting

Document Sample
Onconova Presents Positive Clinical Results for Rigosertib at ASH Meeting Powered By Docstoc
					
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:19
posted:12/10/2012
language:Japanese
pages:4
Description: NEWTOWN, Pa. & PENNINGTON, N.J.--(BUSINESS WIRE)--Onconova Therapeutics, Inc. today announced three presentations relating to clinical trials of its Phase III-stage anti-cancer agent, rigosertib (ON 01910.Na), at the 54th American Society of Hematology (ASH) Annual Meeting in Atlanta, GA, December 8-11, 2012. The presentations highlighted data from Phase I and Phase I/II clinical trials evaluating rigosertib in patients with relapsed/refractory acute myeloid leukemia (AML), myelodysplastic syndr a style='font-si
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.